Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9® to better battle prostate cancer progression
スポンサーリンク
概要
- 論文の詳細を見る
Inflammatory cytokines and chemokines released by macrophages in the prostate cancer microenvironment may signal via the androgen receptor (AR ) to influence tumor progression. In particular, macrophages appear to promote tumorigenesis by altering the chemokine (C-C motif) ligand 4 (CCL4)/AR signaling axis. This process can be blocked by AS C-J9®, an enhancer of AR degradation. AS C-J9® also inhibits the CCL2-dependent, signal transducer and activator of transcription 3 (STAT3)-mediated pro-metastatic signaling cascade that is generally activated by androgen deprivation therapy. Thus, targeting inflammatory cytokines signaling via the AR , with AS C-J9®, represents a promising therapeutic approach against prostate cancer progression. © 2013 Landes Bioscience.
- Landes Bioscienceの論文
Landes Bioscience | 論文
- Photosynthesis-dependent Ca2+influx and functional diversity between phospholipases in the formation of cell polarity in migrating cells of red algae
- Effects of cell wall synthesis on cell polarity in the red alga Porphyra yezoensis
- Suppressive Effect of Modified Dominant Negative RAS Mutant on Human Cancer by Gene Transfer with Non-Viral Vector
- Alternative efficacy-predicting markers for paclitaxel instead of CHFR in non-small cell lung cancer
- Protective role of MyD88-independent innate immune responses against prion infection